Imaflex (IFX) AI Stock Analysis

• Market Cap: C$67.72M
• Dividend Yield: N/A
• Average Volume (3M): 4.97K
• Price to Earnings (P/E): 11.5
• Beta (1Y): 0.12
• Revenue Growth: 13.92%
• EPS Growth: 310.18%
• Country: CA
• Employees: 269
• Sector: Industrials
• Sector Strength: 95
• Industry: Packaging & Containers
• EPS (TTM): 0.01
• Shares Outstanding: 52,088,640
• 10 Day Avg. Volume: 6,237
• 30 Day Avg. Volume: 4,972
• PEG Ratio: -0.53
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 4.54
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$2.72
• Price Target Upside: 109.23% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 74 Outperform
• Price Target: C$1.50 ▲(15.38%Upside)

The overall stock score reflects Imaflex's strong financial performance and reasonable valuation. The company's low leverage and robust cash flow generation are significant strengths. While technical indicators show moderate momentum, the absence of a dividend yield and slight net income decline are minor concerns. Corporate events further reinforce the company's positive outlook.

Imaflex Business Overview & Revenue Model

Company Description

Imaflex Inc., together with its subsidiaries, develops, manufactures, and sells flexible packaging materials for industrial and agriculture markets in Canada, the United States, and internationally. It offers plastic films; agricultural films, including mulch, solarization, fumigation, compostable, and crop protection films; converter films; and industrial bags, such as garbage, compostable, and gaylord bags, as well as bags on roll products. The company primarily operates under the Shine N' Ripe XL and ADVASEAL brand names. It sells its products to printers who process the film into a to meet their end-customer needs, as well as directly to customers. The company was founded in 1994 and is headquartered in Montreal, Canada.

How the Company Makes Money

Imaflex generates revenue primarily through the sale of its polyethylene films and bags. The company's key revenue streams include product sales to the agricultural sector, where its films are used for crop protection and enhancement, and to the consumer and industrial sectors, which utilize its packaging solutions for various goods. Imaflex's earnings are bolstered by its ability to offer customized products that cater to specific customer needs, thereby securing long-term contracts and repeat business. Additionally, Imaflex's focus on innovation and sustainability allows it to differentiate its offerings in a competitive market, driving growth and profitability.

Imaflex Financial Statement Overview

Summary

Imaflex demonstrates strong financial health with steady growth in revenue and profitability. The balance sheet shows low leverage and effective equity utilization. Cash flow remains robust, supporting the company's financial stability, despite a minor decline in net income.

Income Statement

The income statement shows healthy growth and profitability. The TTM (Trailing-Twelve-Months) data indicates a gross profit margin of 16.62% and a net profit margin of 5.28%, which are solid figures in the packaging industry. The revenue growth rate from the previous year is 1.39%, demonstrating stable growth. EBIT and EBITDA margins are 7.36% and 11.37% respectively, indicating good operational efficiency. However, there is a slight decline in net income compared to the previous annual report.

Balance Sheet

The balance sheet reflects a strong equity position with a debt-to-equity ratio of 0.15, indicating low leverage. The return on equity (ROE) is 9.05% for the TTM period, showcasing decent returns for shareholders. The equity ratio of 70.49% suggests a robust capital structure, though there's a slight decrease in stockholders' equity compared to the previous year.

Cash Flow

Cash flow analysis highlights strong free cash flow generation, with a significant growth rate of 30.34% from the previous period. The operating cash flow to net income ratio is 3.01, and free cash flow to net income ratio is 2.50, indicating efficient cash conversion. The company maintains strong cash flow management despite fluctuations in capital expenditures.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	109.85M	93.59M	111.53M	107.48M	86.68M
Gross Profit	17.61M	11.01M	18.05M	17.40M	16.57M
EBITDA	14.44M	6.02M	14.13M	14.19M	12.88M
Net Income	7.46M	508.78K	9.13M	8.37M	6.35M
Balance Sheet
Total Assets	96.09M	78.45M	72.00M	64.99M	54.06M
Cash, Cash Equivalents and Short-Term Investments	8.96M	799.13K	7.53M	8.47M	3.22M
Total Debt	10.13M	11.41M	8.03M	9.57M	9.79M
Total Liabilities	31.42M	22.59M	16.85M	19.92M	18.08M
Stockholders Equity	64.67M	55.86M	55.15M	45.07M	35.98M
Cash Flow
Free Cash Flow	11.25M	-7.58M	2.67M	5.58M	10.30M
Operating Cash Flow	15.00M	5.44M	17.27M	8.05M	11.96M
Investing Cash Flow	-3.75M	-13.02M	-14.60M	-2.47M	-1.61M
Financing Cash Flow	-3.93M	859.92K	-3.62M	-304.06K	-7.16M

Imaflex Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IFX, the sentiment is Positive. The current price of 1.3 is above the 20-day moving average (MA) of 1.29, above the 50-day MA of 1.29, and below the 200-day MA of 1.32, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 52.85 is Neutral, neither overbought nor oversold. The STOCH value of 23.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IFX.

Imaflex Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IFX	74 Outperform	C$67.72M	11.52	9.56%	―	13.92%	310.18%
SXP	73 Outperform	C$103.15M	―	-10.60%	4.52%	-3.15%	-222.64%
DCM	66 Neutral	C$91.26M	12.66	21.19%	3.03%	-5.30%	―
WPK	65 Neutral	C$2.47B	12.80	10.79%	0.18%	4.69%	4.54%
Sector *	61 Neutral	C$6.56B	7.72	2.76%	2.57%	6.48%	-23.55%
PYR	41 Neutral	C$76.80M	―	-5701.32%	―	14.45%	76.75%
CADNF	―	$682.85M	―	-0.24%	5.05%	―	―

Imaflex Corporate Events

Imaflex Inc. Confirms Board Re-Elections and Auditor Re-Appointment at AGM

Imaflex Inc. announced the results of its Virtual Annual General Meeting, where all incumbent directors were re-elected, and Stephan Yazedjian was elected as a new director. The re-appointment of the Corporation’s auditors was also approved, indicating stability and continuity in Imaflex’s governance, which could positively impact its operations and stakeholder confidence.

The most recent analyst rating on (TSE:IFX) stock is a Buy with a C$2.00 price target. To see the full list of analyst forecasts on Imaflex stock, see the TSE:IFX Stock Forecast page.

Imaflex Inc. Reports Strong Q1 2025 Results Amid Challenges

Imaflex Inc. reported a 5.5% increase in Q1 2025 revenues to $28.9 million and a 27.9% growth in adjusted EBITDA, despite a challenging quarter marked by a cybersecurity incident. The company’s resilience and operational efficiencies allowed it to maintain growth and profitability, positioning it well for future opportunities and long-term growth.

The most recent analyst rating on (TSE:IFX) stock is a Buy with a C$2.00 price target. To see the full list of analyst forecasts on Imaflex stock, see the TSE:IFX Stock Forecast page.